期刊
NEUROLOGY
卷 64, 期 8, 页码 1450-1451出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.WNL.0000158652.74601.48
关键词
-
Pergolide is a dopamine agonist that improves Parkinson disease but is associated with dose-dependent sleepiness. This study evaluates the effect of a nighttime dose of 1 mg of pergolide on actigraphic measures of sleep using a randomized, double-blind, placebo-controlled study design. The pergolide group ( n = 10) worsened in actigraphic measures of sleep efficiency and sleep fragmentation vs the placebo group ( n = 12). Side effects were more frequent in the pergolide group.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据